Bernardino CM, Ortiz MR, Álvarez FB, Cabanillas VL, García HP, Ramos AJT

Language: Spanish
References: 18
Page: 17-21
PDF size: 162.25 Kb.

ABSTRACT

Group B Streptococcus, or Streptococcus agalactiae is a major causative agent of bacterial infection in newborns, with two clinical forms of onset: early and late. Of the latter, several transmission mechanisms are known: horizontal, nosocomial or community acquired. There are few cases reported in the literature about milk intake colonized by group B streptococci as a cause of late infection in the newborn. A case of a newborn who suffered late-onset sepsis and meningitis caused by group B strep, transmitted through breast mi k in a mother without mastitis and describes the pathogenesis of this disease and the controversy about the maternal treatment or removal of breastfeeding in these cases.

REFERENCES

1. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51 (RR- 11):1-22.

2. Prieto Tato LM, Gimeno Diaz de Atauri A. Aracil Santos J, Omeñaca Teres F, del Castillo Martin F y col. Infección tardía por estreptococo del grupo B: experiencia en un hospital de tercer nivel (2000-2006). An Pediatr (Barc) 2008; 68(3):239- 243.

3. Kotiw M, Zhang GW, Daggard G , Reiss-Levy E , Tapsall JW. Late-onset and recurrent neonatal group B streptococcal disease associated with breast-milk transmission. Pediatr Dev Pathol 2003; 6(3):251-256.

4. Olver William J, Bond David W, Boswell Tim C, Watkin SL. Neonatal group B streptococcal disease associated with infected breast milk. Arch Dis Child Fetal Neonatal Ed 2000;83:48-49.

5. Arias-Camison JM. Late onset group B streptococcal infection from maternal expressed breast milk in a very low birth weight infant. J Perinatol 2003;23(8):691-692.

6. Godambe S, Shah PS, Shah V. Breast mi k as a source of late onset neonatal sepsis. Pediatr Infect Dis J 2005;24(4):381- 382.

7. Dinger J, Müller D, Pargac N, Schwarze R. Breast mi k transmission of group B streptococcal infection. Pediatr Infect Dis J 2002;21(6):567-568.

8. Edwards MS, Muñoz FM, Baker CJ. Ant bodies to type III group B streptococcal polysaccharide in breast milk. Pediatr Infec Dis J 2004;23(10):961-963.

9. Fluegge K, Supper S, Siedler A, Berner R. Serotype distr bution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in Germany. Clin Infect Dis 2005;40(5):760-763.

10. Weisner AM, Johnson AP, Lamagni TL, Arnold E, Warner M, et al. Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis 2004;38(9):1203–1208.

11. Kubin V, Mrastikova H, Paulova M, Motlova J, Franek J. Group B streptococci in the milk of lactating mothers. Zentralbl Bakteriol Mikrobiol Hyg 1987;265(1-2):210–217.

12. Baker CJ, Edwards MS. Group B streptococcal conjugate vaccines. Arch Dis Child 2003;88(5):375-378.

13. Verani JR, Schrag SJ. Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin Perinatol 2010;37(2):375-392.

14. Edwards MS. Group B streptococcal conjugate vaccine: a timely concept for which the time has come. Hum Vaccin 2008;4(6):444-448.

15. Kasper DL, Paoletti LC, Wessels MR, Guttormsen HK, Carey VJ, et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest 1996;98(10):2308-2314.

16. Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine 2003;21(24):3468-3472.

17. Baker CJ, Paoletti LC, Wessels MR, Guttormsen HK, Rench MA, et al. Safety and immunogenicity of capsular polysaccharide- tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999;179(1):142- 150.

18. Baker CJ, Paoletti LC, Rench MA, Guttormsen HK, Carey VJ, et al. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. J Infect Dis 2000182(4):1129-1138.